Home | About PM | Editorial board | Search | Ahead of print | Current Issue | Archives | Instructions | Subscribe | Advertise | Contact us |  Login 
Pharmacognosy Magazine
Search Article 
  
Advanced search 
 
This article has been cited by
1
Alka Mukne,Misbah Momin,Parag Betkar,Tanvi Rane,Saurabh Valecha
.2021;()211
[DOI]
2Screening for PPAR Non-Agonist Ligands Followed by Characterization of a Hit, AM-879, with Additional No-Adipogenic and cdk5-Mediated Phosphorylation Inhibition Properties
Helder Veras Ribeiro Filho,Natália Bernardi Videira,Aline Villanova Bridi,Thais Helena Tittanegro,Fernanda Aparecida Helena Batista,José Geraldo de Carvalho Pereira,Paulo Sérgio Lopes de Oliveira,Marcio Chaim Bajgelman,Albane Le Maire,Ana Carolina Migliorini Figueira
Frontiers in Endocrinology.2018;9()211
[DOI]
3Design, sythesis and evaluation of a series of 3- or 4-alkoxy substituted phenoxy derivatives as PPARs agonists
Jun Zhang,Xue-Jiao Wang,Xin Liu,Yi Huan,Miao-Miao Yang,Zhu-Fang Shen,Wen-Qing Jia,Zhi Jing,Shu-Qing Wang,Wei-Ren Xu,Xian-Chao Cheng,Run-Ling Wang
Oncotarget.2017;8(13)20766
[DOI]
4Halophytic Grasses, a New Source of Nutraceuticals? A Review on Their Secondary Metabolites and Biological Activities
Maria Faustino,Maria Faustino,Diana Pinto
International Journal of Molecular Sciences.2019;20(5)1067
[DOI]
5An Integrative Pharmacology-Based Approach for Evaluating the Potential Effects of Purslane Seed in Diabetes Mellitus Treatment Using UHPLC-LTQ-Orbitrap and TCMIP V2.0
Jinli Hou,Xiang Zhou,Ping Wang,Chunhui Zhao,Yuewen Qin,Feng Liu,Liping Yu,Haiyu Xu
Frontiers in Pharmacology.2021;11(5)1067
[DOI]
  Feedback 
  Subscribe